Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012


Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011, and 2012 (P50)


PAR 10-003:
Expiration date: September 21, 2012

Rajeev K. Agarwal, Ph.D.

On October 2, 2009, TRP reissued a funding opportunity for an additional three years that uses the P50 (Specialized Centers) funding mechanism, and is open to all organ-based cancer research.

SPOREs foster highly interactive, translational cancer research based on a unique approach with the following characteristics: a minimum of four translational cancer research projects with a human end-point within the five-year funding period; a team-science (basic and applied) approach in each research project; a pathology/biospecimen specialized resource core; a developmental research program to promote pilot projects or cutting-edge research (basic, clinical or translational); a career development program to promote both the transition of young or established investigators to translational cancer research in the proposed organ site; the requirement for collaboration among other SPOREs and across NCI-funded networks to promote translational advancement; the flexibility to realign resources if translational objectives are not being met during the course of the funding period; and the active advice of patient advocates. Additional information can be obtained in the SPORE guidelines (